SUNPHARMA.NS vs. AUROPHARMA.NS
Compare and contrast key facts about Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Aurobindo Pharma Limited (AUROPHARMA.NS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SUNPHARMA.NS or AUROPHARMA.NS.
Correlation
The correlation between SUNPHARMA.NS and AUROPHARMA.NS is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SUNPHARMA.NS vs. AUROPHARMA.NS - Performance Comparison
Key characteristics
SUNPHARMA.NS:
0.60
AUROPHARMA.NS:
0.29
SUNPHARMA.NS:
0.95
AUROPHARMA.NS:
0.62
SUNPHARMA.NS:
1.12
AUROPHARMA.NS:
1.07
SUNPHARMA.NS:
0.84
AUROPHARMA.NS:
0.28
SUNPHARMA.NS:
1.90
AUROPHARMA.NS:
0.63
SUNPHARMA.NS:
6.09%
AUROPHARMA.NS:
12.53%
SUNPHARMA.NS:
19.21%
AUROPHARMA.NS:
27.47%
SUNPHARMA.NS:
-71.46%
AUROPHARMA.NS:
-86.50%
SUNPHARMA.NS:
-13.82%
AUROPHARMA.NS:
-28.49%
Fundamentals
SUNPHARMA.NS:
₹4.02T
AUROPHARMA.NS:
₹659.33B
SUNPHARMA.NS:
₹47.64
AUROPHARMA.NS:
₹59.80
SUNPHARMA.NS:
35.19
AUROPHARMA.NS:
18.98
SUNPHARMA.NS:
₹513.64B
AUROPHARMA.NS:
₹306.87B
SUNPHARMA.NS:
₹317.10B
AUROPHARMA.NS:
₹151.71B
SUNPHARMA.NS:
₹161.31B
AUROPHARMA.NS:
₹67.45B
Returns By Period
In the year-to-date period, SUNPHARMA.NS achieves a -10.97% return, which is significantly higher than AUROPHARMA.NS's -16.04% return. Over the past 10 years, SUNPHARMA.NS has underperformed AUROPHARMA.NS with an annualized return of 7.25%, while AUROPHARMA.NS has yielded a comparatively higher 8.75% annualized return.
SUNPHARMA.NS
-10.97%
-5.30%
-4.07%
9.15%
34.72%
7.25%
AUROPHARMA.NS
-16.04%
-5.54%
-26.89%
7.92%
14.27%
8.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SUNPHARMA.NS vs. AUROPHARMA.NS — Risk-Adjusted Performance Rank
SUNPHARMA.NS
AUROPHARMA.NS
SUNPHARMA.NS vs. AUROPHARMA.NS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Aurobindo Pharma Limited (AUROPHARMA.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SUNPHARMA.NS vs. AUROPHARMA.NS - Dividend Comparison
SUNPHARMA.NS's dividend yield for the trailing twelve months is around 0.93%, while AUROPHARMA.NS has not paid dividends to shareholders.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SUNPHARMA.NS Sun Pharmaceutical Industries Limited | 0.93% | 0.72% | 0.91% | 1.00% | 0.89% | 0.68% | 0.64% | 0.46% | 0.61% | 0.16% | 0.37% | 0.18% |
AUROPHARMA.NS Aurobindo Pharma Limited | 0.00% | 0.11% | 0.55% | 1.37% | 0.61% | 0.46% | 0.55% | 0.31% | 0.40% | 0.40% | 0.30% | 0.29% |
Drawdowns
SUNPHARMA.NS vs. AUROPHARMA.NS - Drawdown Comparison
The maximum SUNPHARMA.NS drawdown since its inception was -71.46%, smaller than the maximum AUROPHARMA.NS drawdown of -86.50%. Use the drawdown chart below to compare losses from any high point for SUNPHARMA.NS and AUROPHARMA.NS. For additional features, visit the drawdowns tool.
Volatility
SUNPHARMA.NS vs. AUROPHARMA.NS - Volatility Comparison
The current volatility for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) is 7.38%, while Aurobindo Pharma Limited (AUROPHARMA.NS) has a volatility of 11.33%. This indicates that SUNPHARMA.NS experiences smaller price fluctuations and is considered to be less risky than AUROPHARMA.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SUNPHARMA.NS vs. AUROPHARMA.NS - Financials Comparison
This section allows you to compare key financial metrics between Sun Pharmaceutical Industries Limited and Aurobindo Pharma Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities